CRISPR infusion eases symptoms in genetic disease.
Science (New York, N.Y.), 377(6613): 1367 PMID 36137027 DOI 10.1126/science.ade9805
Abstract
Some patients no longer need drugs to prevent swelling.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.